Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Stemtech (STEK) Return on Sales (2020 - 2025)

Stemtech's Return on Sales history spans 5 years, with the latest figure at 0.95% for Q3 2025.

  • For Q3 2025, Return on Sales rose 18.0% year-over-year to 0.95%; the TTM value through Sep 2025 reached 0.79%, up 23.0%, while the annual FY2024 figure was 0.75%, 36.0% up from the prior year.
  • Return on Sales for Q3 2025 was 0.95% at Stemtech, down from 0.42% in the prior quarter.
  • Across five years, Return on Sales topped out at 16.61% in Q3 2022 and bottomed at 19.56% in Q2 2022.
  • The 5-year median for Return on Sales is 0.75% (2021), against an average of 1.15%.
  • The largest YoY upside for Return on Sales was 2246bps in 2022 against a maximum downside of -1881bps in 2022.
  • A 5-year view of Return on Sales shows it stood at 0.65% in 2021, then increased by 22bps to 0.5% in 2022, then crashed by -173bps to 1.37% in 2023, then soared by 78bps to 0.3% in 2024, then tumbled by -216bps to 0.95% in 2025.
  • Per Business Quant, the three most recent readings for STEK's Return on Sales are 0.95% (Q3 2025), 0.42% (Q2 2025), and 1.68% (Q1 2025).